Sales rise 36.98% to Rs 119.56 crore
Net Loss of Orchid Pharma reported to Rs 24.73 crore in the quarter ended March 2021 as against net loss of Rs 38.86 crore during the previous quarter ended March 2020. Sales rose 36.98% to Rs 119.56 crore in the quarter ended March 2021 as against Rs 87.28 crore during the previous quarter ended March 2020.For the full year,net loss reported to Rs 116.53 crore in the year ended March 2021 as against net loss of Rs 131.03 crore during the previous year ended March 2020. Sales declined 6.98% to Rs 450.06 crore in the year ended March 2021 as against Rs 483.81 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales119.5687.28 37 450.06483.81 -7 OPM %-3.18-23.33 -6.33-6.87 - PBDT-4.40-15.65 72 -7.61-13.10 42 PBT-24.73-38.86 36 -116.53-131.03 11 NP-24.73-38.86 36 -116.53-131.03 11
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
